Furthermore, the ROS generation and caspase-3 activity was found to be higher in ZnO NPs-2 treated group as compared to ZnO NPs-1, concluding that smaller-sized ZnO NPs exhibit enhanced cytotoxicity against non-melanoma human cell line (A431). This evidence concerns the gene CASP3 and melanoma.